Page last updated: 2024-10-17

n(1)-methylnicotinamide and Liver Dysfunction

n(1)-methylnicotinamide has been researched along with Liver Dysfunction in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KhodosovskiÄ­, MN1
Zinchuk, VV1
Chlopicki, S1

Other Studies

1 other study available for n(1)-methylnicotinamide and Liver Dysfunction

ArticleYear
[Effect of 1-methylnicotinamide on prooxidant-antioxidant balance parameters in rats during hepatic ischemia-reperfusion].
    Eksperimental'naia i klinicheskaia farmakologiia, 2010, Volume: 73, Issue:4

    Topics: Animals; Antioxidants; Liver; Liver Diseases; Male; Niacinamide; Rats; Rats, Wistar; Reperfusion Inj

2010